Maria Dolores Moya-Garzon

@stanford.edu

Postdoc at Pathology Department
Stanford

RESEARCH, TEACHING, or OTHER INTERESTS

Chemistry, Drug Discovery, Biochemistry, Endocrinology

131

Scholar Citations

7

Scholar h-index

5

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Binding and sequestration of poison frog alkaloids by a plasma globulin
    A Alvarez-Buylla, MT Fischer, MDM Garzon, AE Rangel, EE Tapia, ...
    Elife 12, e85096 2023

  • Organism-wide, cell-type-specific secretome mapping of exercise training in mice
    W Wei, NM Riley, X Lyu, X Shen, J Guo, SH Raun, M Zhao, ...
    Cell Metabolism 35 (7), 1261-1279. e11 2023

  • CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels
    JT Tanzo, VL Li, AL Wiggenhorn, MD Moya-Garzon, W Wei, X Lyu, ...
    Journal of Biological Chemistry 299 (6) 2023

  • Structural insights into the mechanism of leptin receptor activation
    RA Saxton, NA Caveney, MD Moya-Garzon, KD Householder, ...
    Nature Communications 14 (1), 1797 2023

  • Organism-wide secretome mapping uncovers pathways of tissue crosstalk in exercise
    W Wei, NM Riley, X Lyu, X Shen, J Guo, M Zhao, MD Moya-Garzon, ...
    bioRxiv, 2022.11. 21.517385 2022

  • The role of somatosensory innervation of adipose tissues
    Y Wang, VH Leung, Y Zhang, VS Nudell, M Loud, MR Servin-Vences, ...
    Nature 609 (7927), 569-574 2022

  • New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production
    MD Moya-Garzon, B Rodriguez-Rodriguez, C Martin-Higueras, ...
    European Journal of Medicinal Chemistry 237, 114396 2022

  • Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias
    MD Moya-Garzon, JA Gomez-Vidal, A Alejo-Armijo, J Altarejos, ...
    Journal of Personalized Medicine 11 (2), 74 2021

  • Compounds for the treatment of diseases caused by oxalate accumulation
    MD GAVILAN, JAG Vidal, MDM GARZON, ES RUIZ, CM HIGUERAS, ...
    US Patent App. 16/492,750 2020

  • V GEQB ChemBio
    JC Morales, S Martn-Santamara, A Conejo
    2020

  • Sntesis de nuevos compuestos inhibidores de glicolato oxidasa. Aplicacin en hiperoxaluria primaria y evaluacin biolgica
    MD Moya Garzn
    Universidad de Granada 2019

  • Compuestos para el tratamiento de enfermedades causadas por la acumulacin de oxalato
    M Daz Gaviln, JA Gmez Vidal, MD Moya Garzn, E Salido Ruiz, ...
    Oficina Espaola de Patentes y Marcas 2018

  • Salicylic acid derivatives inhibit oxalate production in mouse hepatocytes with primary hyperoxaluria type 1
    MD Moya-Garzn, C Martin Higueras, P Pealver, M Romera, ...
    Journal of Medicinal Chemistry 61 (16), 7144-7167 2018

  • Development of a Cannabinoid-Based Photoaffinity Probe to Determine the Δ8/9-Tetrahydrocannabinol Protein Interaction Landscape in Neuroblastoma Cells
    M Soethoudt, G Alachouzos, EJ van Rooden, MD Moya-Garzn, ...
    Cannabis and Cannabinoid Research 3 (1), 136-151 2018

  • New glycolate oxidase inhibitors as promising drugs for primary hyperoxaluria type 1
    C Martin-Higueras, MD Moya-Garzon, JA Gomez-Vidal, M Diaz-Gavilan, ...
    PEDIATRIC NEPHROLOGY 31 (10), 1892-1892 2016

MOST CITED SCHOLAR PUBLICATIONS

  • The role of somatosensory innervation of adipose tissues
    Y Wang, VH Leung, Y Zhang, VS Nudell, M Loud, MR Servin-Vences, ...
    Nature 609 (7927), 569-574 2022
    Citations: 35

  • Organism-wide, cell-type-specific secretome mapping of exercise training in mice
    W Wei, NM Riley, X Lyu, X Shen, J Guo, SH Raun, M Zhao, ...
    Cell Metabolism 35 (7), 1261-1279. e11 2023
    Citations: 22

  • Salicylic acid derivatives inhibit oxalate production in mouse hepatocytes with primary hyperoxaluria type 1
    MD Moya-Garzn, C Martin Higueras, P Pealver, M Romera, ...
    Journal of Medicinal Chemistry 61 (16), 7144-7167 2018
    Citations: 20

  • Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias
    MD Moya-Garzon, JA Gomez-Vidal, A Alejo-Armijo, J Altarejos, ...
    Journal of Personalized Medicine 11 (2), 74 2021
    Citations: 19

  • Development of a Cannabinoid-Based Photoaffinity Probe to Determine the Δ8/9-Tetrahydrocannabinol Protein Interaction Landscape in Neuroblastoma Cells
    M Soethoudt, G Alachouzos, EJ van Rooden, MD Moya-Garzn, ...
    Cannabis and Cannabinoid Research 3 (1), 136-151 2018
    Citations: 11

  • Structural insights into the mechanism of leptin receptor activation
    RA Saxton, NA Caveney, MD Moya-Garzon, KD Householder, ...
    Nature Communications 14 (1), 1797 2023
    Citations: 9

  • New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production
    MD Moya-Garzon, B Rodriguez-Rodriguez, C Martin-Higueras, ...
    European Journal of Medicinal Chemistry 237, 114396 2022
    Citations: 8

  • Binding and sequestration of poison frog alkaloids by a plasma globulin
    A Alvarez-Buylla, MT Fischer, MDM Garzon, AE Rangel, EE Tapia, ...
    Elife 12, e85096 2023
    Citations: 4

  • CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels
    JT Tanzo, VL Li, AL Wiggenhorn, MD Moya-Garzon, W Wei, X Lyu, ...
    Journal of Biological Chemistry 299 (6) 2023
    Citations: 2

  • Organism-wide secretome mapping uncovers pathways of tissue crosstalk in exercise
    W Wei, NM Riley, X Lyu, X Shen, J Guo, M Zhao, MD Moya-Garzon, ...
    bioRxiv, 2022.11. 21.517385 2022
    Citations: 1